- Report
- December 2024
- 30 Pages
Global
From €1940EUR$2,200USD£1,704GBP
€2424EUR$2,750USD£2,129GBP
- Report
- July 2024
- 150 Pages
Global
From €2645EUR$3,000USD£2,323GBP
€3306EUR$3,750USD£2,904GBP
- Report
- June 2024
- 200 Pages
Global
From €5607EUR$6,360USD£4,925GBP
€7009EUR$7,950USD£6,156GBP
- Report
- June 2023
- 200 Pages
Global
From €5290EUR$6,000USD£4,646GBP
€6612EUR$7,500USD£5,808GBP
- Report
- April 2023
- 240 Pages
Global
From €2469EUR$2,800USD£2,168GBP
€3086EUR$3,500USD£2,710GBP
- Report
- February 2024
- 110 Pages
Global
From €4188EUR$4,750USD£3,678GBP
- Report
- April 2023
- 115 Pages
Global
From €4188EUR$4,750USD£3,678GBP
- Report
- October 2024
- 140 Pages
Global
From €2204EUR$2,500USD£1,936GBP
- Report
- April 2023
- 116 Pages
Global
From €3967EUR$4,500USD£3,485GBP
- Report
- April 2023
- 160 Pages
Global
From €4363EUR$4,949USD£3,832GBP
- Report
- December 2024
- 70 Pages
Global
From €3522EUR$3,995USD£3,093GBP
- Report
- October 2022
- 81 Pages
Global
From €3081EUR$3,495USD£2,706GBP
- Report
- August 2024
- 101 Pages
China
From €1587EUR$1,800USD£1,394GBP
- Report
- August 2024
- 133 Pages
China
From €1587EUR$1,800USD£1,394GBP
- Report
- January 2024
- 109 Pages
United States
€3086EUR$3,500USD£2,710GBP
- Report
- February 2018
- 680 Pages
Global
From €19396EUR$22,000USD£17,035GBP
- Report
- October 2024
- 90 Pages
Global
From €3500EUR$4,253USD£3,182GBP
- Report
- October 2023
- 101 Pages
Global
From €3500EUR$4,253USD£3,182GBP
- Report
- August 2023
- 94 Pages
Global
From €3500EUR$4,253USD£3,182GBP
- Report
- May 2023
- 94 Pages
Global
From €3500EUR$4,253USD£3,182GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more